Established in 1845, Scientific American remains the oldest continuously-published magazine in the United States. Redesigned in October 2010, the publication covers the most important and exciting research in science, health, technology, the environment, and society, exploring important ideas often months and years before other media recognizes their importance. The magazine publishes 15 foreign language editions, and regular sections include Forum, which provides a platform for external experts to comment on science policy; Science Agenda, where editors can discuss different science issues; and Insights, which profiles a scientist or researcher and analyzes their contribution to society. Other sections include Anti Gravity and Skeptic. Regular columns include The Science of Health and TechnoFiles. Publicists should feel free to pitch anytime, although they should avoid pitching individual products or new company officer announcements. They should focus on science-based stories that are better told by a journalist than an expert.

Established in 1899 and written for venture capitalists and hi-tech executives as an informational source on innovative and improved technologies and their applications. Focuses on promoting the understanding of emerging technologies and their impact. Strives to promote the understanding of emerging technology and its impact on the world. Aims to promote the understanding of emerging technologies and to analyze their commercial, social and political impacts. Assists technology and business leaders including CXOs, entrepreneurs, researchers, venture capitalists and financiers as they drive the global economy.

Endpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter.

Established in 1974 and written for hospital and health system executives as an industry-intensive news source. Editorial concentrates on issues, news and trends affecting healthcare in the United States and provides information to healthcare professionals on topics including finance, integrated delivery systems, technology, politics, labor, managed care, physician issues, developments in federal and state government, court rulings, policy and regulation and marketing. There is a particular emphasis on coverage of electronic medical records. Regular features provide up to the minute news and trends in the healthcare field and discusses physician issues, innovative strategies and studies, future developments within this field and personnel updates. Departments include: The Week in Healthcare, Late News, Opinions/Editorials, Cover Story and Features. Topics regularly covered include: human resources, finance, legal affairs, managed care, policy and technology. Special sections included are: Profile, an in-depth look at a healthcare industry leader; Medical Advances, how the latest developments in medicine, biotechnology, pharmaceuticals and medical technology will affect your business; By the Numbers, a look at healthcare statistics and figures; and The Edge, how information technology is helping healthcare management solve clinical, financial and strategic challenges. Modern Healthcare does not publish unsolicited news articles or "byline" articles from outside firms. All of the editorial content is developed by staff or commissioned from freelance writers.

Impact Factor:22.66 (Source: Scimago Journal & Country Rank)Circulation: The figure is not currently disclosed.Aims of the journal:Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition it seeks to provide the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Content: The journal covers the following subjects: Target discovery Rational drug design Combinatorial and parallel synthesis Medicinal chemistry Key compound classes Natural products High-throughput screening Novel therapeutic approaches to disease states Microarrays Bioinformatics and chemoinformatics Absorption, distribution, metabolism and elimination (ADME) Pharmacokinetics and pharmacodynamics Pharmacology Toxicology Pharmacogenomics and toxicogenomics Drug delivery Biopharmaceuticals Biotechnology Vaccines Clinical trial evaluation Regulatory issues PharmacoeconomicsEditorial contacts: See the list of editors here.The editorial office can be reached at naturereviews@nature.com.Manuscript submission:To be published in nature Reviews Drug Discovery a manuscript should meet the following criteria: Timely, accurate and balanced Important to scientists in the specific field Interesting and accessible to researchers in other areas of Drug DiscoverySubmit online at http://mts-nrdd.nature.com/cgi-bin/main.plex